- Home
- MTW vs QURE Comparison
MTW vs QURE Comparison
Compare MTW & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTW
- QURE
- Stock Information
- Founded
- MTW 1902
- QURE 1998
- Country
- MTW United States
- QURE Netherlands
- Employees
- MTW N/A
- QURE N/A
- Industry
- MTW Construction/Ag Equipment/Trucks
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- MTW Industrials
- QURE Health Care
- Exchange
- MTW Nasdaq
- QURE Nasdaq
- Market Cap
- MTW 374.8M
- QURE 432.6M
- IPO Year
- MTW N/A
- QURE 2007
- Fundamental
- Price
- MTW $10.52
- QURE $6.21
- Analyst Decision
- MTW Sell
- QURE Buy
- Analyst Count
- MTW 6
- QURE 6
- Target Price
- MTW $12.47
- QURE $17.00
- AVG Volume (30 Days)
- MTW 374.3K
- QURE 757.3K
- Earning Date
- MTW 10-30-2024
- QURE 11-05-2024
- Dividend Yield
- MTW N/A
- QURE N/A
- EPS Growth
- MTW N/A
- QURE N/A
- EPS
- MTW N/A
- QURE N/A
- Revenue
- MTW $2,177,800,000.00
- QURE $28,587,000.00
- Revenue This Year
- MTW N/A
- QURE $157.96
- Revenue Next Year
- MTW $1.95
- QURE N/A
- P/E Ratio
- MTW N/A
- QURE N/A
- Revenue Growth
- MTW N/A
- QURE N/A
- 52 Week Low
- MTW $8.50
- QURE $3.73
- 52 Week High
- MTW $17.65
- QURE $11.35
- Technical
- Relative Strength Index (RSI)
- MTW 54.52
- QURE 47.23
- Support Level
- MTW $10.48
- QURE $6.51
- Resistance Level
- MTW $11.39
- QURE $7.96
- Average True Range (ATR)
- MTW 0.59
- QURE 0.59
- MACD
- MTW 0.08
- QURE -0.04
- Stochastic Oscillator
- MTW 69.72
- QURE 32.76
About MTW Manitowoc Company Inc. (The)
Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.